Pfizer and Biontech announced that their Covid-19 vaccine is more than 90 % effective, following the "success" of the first interim analysis of their phase 3 trial.
Thus, its candidate for a vaccine based on mRNA, BNT162b2 against SARS-COV-2, confirmed its efficacy against the coronavirus in…
Read More...